CLGN
Price
$1.38
Change
-$0.00 (-0.00%)
Updated
Jun 27, 04:58 PM (EDT)
Capitalization
17.55M
55 days until earnings call
SPRO
Price
$2.94
Change
+$0.04 (+1.38%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
164.66M
40 days until earnings call
Interact to see
Advertisement

CLGN vs SPRO

Header iconCLGN vs SPRO Comparison
Open Charts CLGN vs SPROBanner chart's image
CollPlant Biotechnologies
Price$1.38
Change-$0.00 (-0.00%)
Volume$1.03K
Capitalization17.55M
Spero Therapeutics
Price$2.94
Change+$0.04 (+1.38%)
Volume$17.1K
Capitalization164.66M
CLGN vs SPRO Comparison Chart in %
Loading...
SPRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLGN vs. SPRO commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLGN is a Hold and SPRO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (CLGN: $1.38 vs. SPRO: $2.94)
Brand notoriety: CLGN and SPRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLGN: 51% vs. SPRO: 30%
Market capitalization -- CLGN: $17.55M vs. SPRO: $164.66M
CLGN [@Biotechnology] is valued at $17.55M. SPRO’s [@Biotechnology] market capitalization is $164.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLGN’s FA Score shows that 1 FA rating(s) are green whileSPRO’s FA Score has 1 green FA rating(s).

  • CLGN’s FA Score: 1 green, 4 red.
  • SPRO’s FA Score: 1 green, 4 red.
According to our system of comparison, SPRO is a better buy in the long-term than CLGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SPRO’s TA Score shows that 5 TA indicator(s) are bullish.

  • SPRO’s TA Score: 5 bullish, 5 bearish.

Price Growth

CLGN (@Biotechnology) experienced а -6.12% price change this week, while SPRO (@Biotechnology) price change was -2.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

CLGN is expected to report earnings on Aug 21, 2025.

SPRO is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRO($165M) has a higher market cap than CLGN($17.5M). SPRO YTD gains are higher at: 185.922 vs. CLGN (-61.667). CLGN has higher annual earnings (EBITDA): -13.57M vs. SPRO (-73.06M). SPRO has more cash in the bank: 48.9M vs. CLGN (10.7M). CLGN has less debt than SPRO: CLGN (2.84M) vs SPRO (3.96M). SPRO has higher revenues than CLGN: SPRO (28.3M) vs CLGN (2.47M).
CLGNSPROCLGN / SPRO
Capitalization17.5M165M11%
EBITDA-13.57M-73.06M19%
Gain YTD-61.667185.922-33%
P/E RatioN/A10.75-
Revenue2.47M28.3M9%
Total Cash10.7M48.9M22%
Total Debt2.84M3.96M72%
FUNDAMENTALS RATINGS
CLGN vs SPRO: Fundamental Ratings
CLGN
SPRO
OUTLOOK RATING
1..100
8531
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
9534
P/E GROWTH RATING
1..100
15
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SPRO's Valuation (59) in the Pharmaceuticals Major industry is somewhat better than the same rating for CLGN (94) in the Biotechnology industry. This means that SPRO’s stock grew somewhat faster than CLGN’s over the last 12 months.

SPRO's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as CLGN (100) in the Biotechnology industry. This means that SPRO’s stock grew similarly to CLGN’s over the last 12 months.

SPRO's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as CLGN (98) in the Biotechnology industry. This means that SPRO’s stock grew similarly to CLGN’s over the last 12 months.

SPRO's Price Growth Rating (34) in the Pharmaceuticals Major industry is somewhat better than the same rating for CLGN (95) in the Biotechnology industry. This means that SPRO’s stock grew somewhat faster than CLGN’s over the last 12 months.

CLGN's P/E Growth Rating (1) in the Biotechnology industry is in the same range as SPRO (5) in the Pharmaceuticals Major industry. This means that CLGN’s stock grew similarly to SPRO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SPRO
RSI
ODDS (%)
Bearish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 8 days ago
71%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
SPRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TVRFX77.400.11
+0.14%
Thornburg Small/Mid Cap Core R3
CMCMX8.41N/A
N/A
Conestoga Discovery Investors
HRLVX22.39N/A
N/A
Harbor Large Cap Value Admin
FRIFX12.23N/A
N/A
Fidelity Real Estate Income
GPEOX12.68N/A
N/A
Grandeur Peak Emerg Mkts Opps Inv

CLGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLGN has been loosely correlated with SPRO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CLGN jumps, then SPRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLGN
1D Price
Change %
CLGN100%
+0.36%
SPRO - CLGN
42%
Loosely correlated
+1.55%
CMVLF - CLGN
37%
Loosely correlated
N/A
CLLS - CLGN
33%
Poorly correlated
-2.54%
ASBP - CLGN
25%
Poorly correlated
-3.63%
VOR - CLGN
25%
Poorly correlated
+22.47%
More

SPRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRO has been loosely correlated with ASBP. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRO jumps, then ASBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRO
1D Price
Change %
SPRO100%
+1.55%
ASBP - SPRO
58%
Loosely correlated
-3.63%
CLGN - SPRO
42%
Loosely correlated
+0.36%
ITOS - SPRO
35%
Loosely correlated
-0.60%
XENE - SPRO
32%
Poorly correlated
+0.65%
MGTX - SPRO
30%
Poorly correlated
-0.45%
More